UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029499
Receipt number R000033697
Scientific Title Impact of Surround Flow Irrigation in Ablation Index-guided Pulmonary Vein Isolation: a Prospective Comparative Study on the Unexcitability during Ablation
Date of disclosure of the study information 2017/10/11
Last modified on 2017/10/10 18:53:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of Surround Flow Irrigation in Ablation Index-guided Pulmonary Vein Isolation: a Prospective Comparative Study on the Unexcitability during Ablation

Acronym

Impact of Surround Flow Irrigation in Ablation Index-guided Pulmonary Vein Isolation: a Prospective Comparative Study on the Unexcitability during Ablation

Scientific Title

Impact of Surround Flow Irrigation in Ablation Index-guided Pulmonary Vein Isolation: a Prospective Comparative Study on the Unexcitability during Ablation

Scientific Title:Acronym

Impact of Surround Flow Irrigation in Ablation Index-guided Pulmonary Vein Isolation: a Prospective Comparative Study on the Unexcitability during Ablation

Region

Japan


Condition

Condition

atrial fibrillation

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Unlike the well-established ablation index (AI)-guided pulmonary vein isolation (PVI) using a ThermoCool SmartTouchTM (ST) catheter, safety and efficacy of using a ST Surround Flow (STSF) catheter equipped with entire tip irrigation system remain unclear. To investigate the impact of STSF, we compared the application time and AI for achieving unexcitability between STSF and ST ablation.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To investigate the impact of STSF, we compared the application time and AI for achieving unexcitability between STSF and ST ablation. Point-by-point ablation was performed during pacing by the ablation catheter at each 6 site along the left PVI line. The CF was adjusted to keep 10g. Radiofrequency (RF) energy at 30W was stopped immediately when the unexcitability to pace was achieved for three consecutive stimuli.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Point-by-point ablation was performed during pacing by the ablation catheter at each 6 site along the left PVI line. The CF was adjusted to keep 10g. Radiofrequency (RF) energy at 30W was stopped immediately when the unexcitability to pace was achieved for three consecutive stimuli. To investigate the impact of STSF, we compared the application time and AI for achieving unexcitability between STSF and ST ablation.

Interventions/Control_2

Point-by-point ablation was performed during pacing by the ablation catheter at each 6 site along the left PVI line. The CF was adjusted to keep 10g. Radiofrequency (RF) energy at 30W was stopped immediately when the unexcitability to pace was achieved for three consecutive stimuli. To investigate the impact of STSF, we compared the application time and AI for achieving unexcitability between STSF and ST ablation.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1) ability and willing to give written informed consent 2) paroxysmal and non-paroxysmal atrial fibrillation

Key exclusion criteria

1) age < 20 years 2) left ventricular ejection < 45% 3) left atrial diameter > 50 mm 4) significant valvular heart disease 5) reversible cause of AF 6) sustained or recurrent AF after the direct cardioversion 7) administration of amiodarone 8) intracardiac thrombus 9) inability to take anticoagulant

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Daisuke Horiuchi

Organization

Department of Cardiology, Hirosaki University Graduate School of Medicine

Division name

Advanced Management of Cardiac arrhythmias

Zip code


Address

5 Zaifu-Cho, Hirosaki, 036-8562 Japan

TEL

81-172-39-5056

Email

horiuch@hirosaki-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Daisuke Horiuchi

Organization

Department of Cardiology, Hirosaki University Graduate School of Medicine

Division name

Advanced Management of Cardiac arrhythmias

Zip code


Address

5 Zaifu-Cho, Hirosaki, 036-8562 Japan

TEL

81-172-39-5057

Homepage URL


Email

horiuch@hirosaki-u.ac.jp


Sponsor or person

Institute

Department of Cardiology, Hirosaki University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Cardiology, Hirosaki University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2017 Year 10 Month 10 Day

Date of IRB


Anticipated trial start date

2017 Year 11 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 10 Month 10 Day

Last modified on

2017 Year 10 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033697


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name